Replies to post #68236 on Bioelectronics Corp (BIEL)

[RVC]

Relative-to-recent-sales-channels-having-been-added

Now beginning to see how the company can mislead when the information being presented is not read in detail.

The company benefits from investors not reading between the lines of the vagueness of the PR's.

IE: "There is no reason we should not have FDA clearance by the year end"
Many interpreted this as inferring there would be FDA clearance by year end 2015.

IE: "The 1st order received for ...."
Without the number of units sold, could have been an order for 1 unit.